Tech Company Financing Transactions
Fauna Bio Funding Round
Lifeforce Ventures, Arcadia and BioMed Ventures participated in a $9 million Seed capital raise for Fauna Bio. This VC investment round was announced by the company on 9/23/2021.
Transaction Overview
Company Name
Announced On
9/23/2021
Transaction Type
Venture Equity
Amount
$9,000,000
Round
Seed
Investors
Lifeforce Ventures (Lead Investor)
True Ventures (Rohit Sharma)
Proceeds Purpose
The company intends to use the funds to expand its drug discovery platform Convergence while accelerating the discovery of new therapeutic targets for human diseases across a broad range of indications.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
6460 Hollis St.
Emeryville, CA 94608
USA
Emeryville, CA 94608
USA
Phone
Undisclosed
Website
Email Address
Not Recorded
Overview
Fauna Bio is inspired by the untapped potential of non-model organism biology. We leverage insights from extraordinary mammalian phenotypes to develop novel translational therapeutics for disease prevention and reduce the impact of age-related diseases in humans.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Ashley Zehnder
Chief Scientific Officer
Katie Grabek
Chief Technical Officer
Linda Goodman
Browse more venture capital transactions:
Prev: 9/23/2021: Rose Technology venture capital transaction
Next: 9/23/2021: 858 Therapeutics venture capital transaction
Share this article
Where The Data Comes From
We do our best to record every notable VC transaction. VC investment data records reported here are derived from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs